These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6607392)

  • 21. Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy.
    Clark D; Furmidge LJ; Petry N; Tong ZY; Ericsson M; Johnson D
    Psychopharmacology (Berl); 1991; 105(3):381-92. PubMed ID: 1686815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance to some behavioural effects of lisuride, a dopamine receptor agonist, and reverse tolerance to others, after repeated administration.
    Carruba MO; Ricciardi S; Chiesara E; Spano PF; Mantegazza P
    Neuropharmacology; 1985 Mar; 24(3):199-206. PubMed ID: 4039419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors.
    Kujacic M; Svensson K; Löfberg L; Carlsson A
    J Neural Transm Gen Sect; 1991; 84(3):195-209. PubMed ID: 1679336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat.
    Lannes B; Micheletti G; Warter JM; Kempf E; Di Scala G
    Neurosci Lett; 1991 Jul; 128(2):177-81. PubMed ID: 1945038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
    Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
    Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.
    Hjorth S; Carlsson A
    J Neural Transm; 1988; 72(2):83-97. PubMed ID: 2968439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH; Rossetti ZL; Meloni M; Frau MI; Gessa GL
    Eur J Pharmacol; 1983 Aug; 91(4):463-8. PubMed ID: 6413231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of S (+)-3-phenethyl-PP, a putative dopamine autoreceptors agonist with greater autoreceptor selectivity than 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Hyttel J; Larsen JJ; Svendsen O
    Eur J Pharmacol; 1984 Jun; 102(1):91-9. PubMed ID: 6148247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Psychopharmacology (Berl); 1983; 81(3):199-207. PubMed ID: 6139838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
    van Oene JC; de Vries JB; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):304-11. PubMed ID: 6514014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.
    Tissari AH; Atzori L; Galdieri MT
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):89-91. PubMed ID: 6843693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent dopamine agonist activity of a novel ergoline, 6-ethyl-9-oxaergoline (EOE).
    Martin GE; Williams M; Clineschmidt BV; Yarbrough GG; Jones JH; Haubrich DR
    Life Sci; 1982 May; 30(21):1847-56. PubMed ID: 7201555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of morphine with apomorphine: behavioural and biochemical studies.
    Möller HG; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):452-7. PubMed ID: 3821935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lisuride, LY-141865, and 8-OH-DPAT facilitate male rat sexual behavior via a non-dopaminergic mechanism.
    Ahlenius S; Larsson K
    Psychopharmacology (Berl); 1984; 83(4):330-4. PubMed ID: 6238339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.